Medical conditions ranging from breast cancer to Post Traumatic Stress Disorder could be diagnosed much more quickly through research being done by Queensland researchers working with US artificial intelligence technology.
As part of her trade mission to the United States, Queensland Premier Annastacia Palaszczuk saw the work being undertaken by the team from the Innovation and Translation Centre at Brisbane’s Translational Research Institute (TRI).
Queensland Government’s Advance Queensland program had supported the TRI’s Innovation and Translation Centre, allowing the TRI to collaborate with Siemens Heathineers at Draper Laboratory in Massachusetts.
The team from TRI and Siemens Healthineers are using an extension of Magnetic Resonance Imaging (MRI) technology called magnetic resonance spectroscopy (MRS).
MRS allows researchers to learn more about the chemical content of tissues and organs, providing a deeper understanding and earlier detection of conditions like PTSD.
“TRI’s goal is to turn this research into a new medical technology to improve the diagnosis of conditions such as PTSD,” the Premier said.
“For the first time, medical clinicians will be able to identify the changes in a patient’s brain chemistry associated with Post Traumatic Stress Disorder (PTSD) or blast injury.
“MRS also offers the ability to assess women at high risk of breast cancer in whom very early tissue changes can be identified.
“We hope this breakthrough will give a greater insight into these conditions and diseases, allowing for quicker diagnoses.
“For example, with breast cancer, it is hoped the technology will detect the cellular changes leading to the disease years before the cancer emerges.”
TRI CEO Professor Carolyn Mountford said the newly developed scanning technologies and techniques would provide a better platform for the diagnosis, monitoring and treatment of cancer, trauma, immunotherapy, chronic pain and other disorders and diseases.
“This will be a game-changer, as we will soon have the technology available to us to have a non-invasive test for PTSD to determine if soldiers and emergency workers are prone to the disorder and if so, can be rested or not immediately deployed again,” Professor Mountford said.